Column Group LLC Long-Term Concentrated

CIK: 0001833486 · Show all filings

Period: Q2 2024 (← Previous) (Next →)

Filing Date: Aug 15, 2024

Total Value ($000): $71,281 (100.0% shares, 0.0% debt)

Holdings (6)

TNYA Tenaya Therapeutics, Inc. 40.9%

Value ($000) $29,141 Shares 9,400,290 Est. Cost $21.49 Unrealized -80.8%

ORIC ORIC Pharmaceuticals Inc. 35.1%

Value ($000) $25,033 Shares 3,540,777 Est. Cost $28.69 Unrealized -68.8%

— Surrozen, Inc. 12.4%

Value ($000) $8,870 Shares 810,088 Est. Cost $7.82 Unrealized —

— RAPT Therapeutics Inc 11.5%

Value ($000) $8,176 Shares 2,680,621 Est. Cost $19.03 Unrealized —

SGMT Sagimet Biosciences Inc. 0.1%

Value ($000) $59 Shares 17,169 Est. Cost $7.18 Unrealized -36.1%

RVMD Revolution Medicines Inc 0.0%

Value ($000) $2 Shares 46 Est. Cost $34.24 Unrealized +9.2%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
TNYA	Tenaya Therapeutics, Inc.	9,400,290	$29,141	40.9%	$21.49	-80.8%	COM	87990A106
ORIC	ORIC Pharmaceuticals Inc.	3,540,777	$25,033	35.1%	$28.69	-68.8%	COM	68622P109
—	Surrozen, Inc.	810,088	$8,870	12.4%	$7.82	—	COM	86889P109
—	RAPT Therapeutics Inc	2,680,621	$8,176	11.5%	$19.03	—	COM	75382E109
SGMT	Sagimet Biosciences Inc.	17,169	$59	0.1%	$7.18	-36.1%	COM	786700104
RVMD	Revolution Medicines Inc	46	$2	0.0%	$34.24	+9.2%	COM	76155X100